INTRODUCTION: Approximately 1-2% of non-small cell lung cancers (NSCLCs) are positive for rearranged during transfection ( METHODS: This observational study was conducted in 2020 in nine countries using electronic patient record forms, following Adelphi Disease Specific Programme (DSP™) methodology. Patients with advanced NSCLC (aNSCLC) were included in the overall cohort. A smaller RESULTS: Patient characteristics were generally similar between the overall aNSCLC cohort (n=2947) and the CONCLUSIONS: Results of this real-world study provide insights into clinical characteristics, biomarker testing, and treatment patterns of patients with